To review the regulatory role of HIF-1α in ferroptosis following ischemic stroke and explore its potential as a therapeutic target.
Approach:
Literature Review: The article reviews studies on HIF-1α's involvement in ferroptosis, focusing on its dual regulatory effects and mechanisms.
Key Findings:
HIF-1α regulates ferroptosis through mechanisms involving iron metabolism, lipid peroxidation, and oxidative stress, with effects influenced by the timing and severity of ischemia.
HIF-1α exhibits both inhibitory and promotive effects on ferroptosis.
Therapeutic strategies to modulate HIF-1α levels include prolyl hydroxylase inhibitors, deferoxamine, and other compounds.
Interpretation:
The dual role of HIF-1α in regulating ferroptosis is linked to dynamic changes in its expression during ischemic events.
Limitations:
Clinical translation of therapeutic strategies is limited by a narrow therapeutic window and potential side effects.
Insufficient clinical validation of proposed therapies.
Conclusion:
Further studies are needed to clarify HIF-1α's dual role in ferroptosis and to develop effective therapeutic strategies.
